肿瘤临床实验英文缩写大全

肿瘤临床实验英文缩写大全
Clinical Trials Abbreviations in Oncology Research
Introduction
Clinical trials play a crucial role in the field of oncology research. They provide a platform for studying and evaluating new treatment approaches, drugs, and interventions for cancer patients. These trials are often associated with a variety of complex terminologies and abbreviations. This article aims to provide a comprehensive list of commonly used abbreviations in the context of oncology clinical trials.
Abbreviations
1. CT: Clinical Trial
2. RCT: Randomized Controlled Trial
3. PFS: Progression-Free Survival
4. OS: Overall Survival
5. ORR: Overall Response Rate
6. DLT: Dose-Limiting Toxicity
7. AE: Adverse Event
8. ECOG: Eastern Cooperative Oncology Group
9. NCI: National Cancer Institute
10. FDA: Food and Drug Administration
11. RECIST: Response Evaluation Criteria in Solid Tumors
12. CR: Complete Response
13. PR: Partial Response
14. SD: Stable Disease
15. PD: Progressive Disease
16. HR: Hazard Ratio
17. CI: Confidence Interval
18. QoL: Quality of Life
19. EORTC: European Organization for Research and Treatment of Cancer
20. ICF: Informed Consent Form
21. ITT: Intention-to-Treat
22. PK: Pharmacokinetics
23. PD-L1: Programmed Death-Ligand 1
24. TTP: Time to Progression
25. HRQoL: Health-Related Quality of Life
26. SAE: Serious Adverse Event
27. BMI: Body Mass Index
28. CTC: Circulating Tumor Cells
29. HDR: High-Dose Radiation
Conclusion
Understanding the abbreviations used in clinical trials is essential for researchers, healthcare professionals, and patients involved in oncology research. It allows efficient and clear communication, facilitating the smooth conduct and interpretation of clinical trial results. This comprehensive list of abbreviations serves as a valuable resource for those working in the field of oncology clinical trials, ensuring accurate understanding and interpretation of the terminology commonly used in this specialized area of research.。